Lars Hanker
7PUBLICATIONS
75CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 25, 2024
Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.Janice S Kwon, Helen McTaggart-Cowan, Sarah E Ferguson
|Oct 24, 2024
Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression.Jonathan Krell, Danielle Shaw, John McGrane
|Jan 11, 2023
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1).Eva Roser, Philipp Harter, Dario Zocholl
|Nov 04, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.Jacobus Pfisterer, Florence Joly, Gunnar Kristensen
|Aug 24, 2022
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer
|Dec 28, 2021
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss
Pageof 2
Frequent Collaborators
3 joint publications
Florian Heitz
3 joint publications
Tjoung-Won Park-Simon
2 joint publications
Jacobus Pfisterer
2 joint publications
Stefan Kommoss
2 joint publications
Klaus Baumann
2 joint publications
Annette Hasenburg
2 joint publications
Christian Jackisch
2 joint publications
Willibald Schröder
2 joint publications
Felix Hilpert
2 joint publications
Philipp Harter
